Skip to main content

Nyxoah SA (NYXH)

NASDAQ: NYXH · IEX Real-Time Price · USD
21.00 -9.00 (-30.00%)
Dec 7, 2021 3:59 PM EST - Market closed
Market Cap546.48M
Revenue (ttm)309,000
Net Income (ttm)-18.91M
Shares Out26.02M
EPS (ttm)-0.73
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume906
Open20.36
Previous Close30.00
Day's Range20.36 - 21.00
52-Week Range19.05 - 37.00
Betan/a
AnalystsStrong Buy
Price Target42.19 (+100.9%)
Earnings Daten/a

About NYXH

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, or OSA. Our lead solution is the Genio system, a CE-Marked, patient-centric, minimally invasive, next generation hypoglossal neurostimulation therapy for the treatment of moderate to severe OSA. Our innovative technology platform is a first-of-its-kind bilateral hypoglossal nerve stimulation device designed to treat OSA, by maintaining an open airway for a restful night’s sleep. We started generatin...

IndustryMedical Instruments & Supplies
IPO DateJul 2, 2021
CEOOlivier Taelman
Employees71
Stock ExchangeNASDAQ
Ticker SymbolNYXH
Full Company Profile

Financial Performance

Financial numbers in millions EURFinancial Statements

Analyst Forecast

According to 3 analysts, the average rating for Nyxoah stock is "Strong Buy." The 12-month stock price forecast is 42.19, which is an increase of 100.90% from the latest price.

Price Target
$42.19
(100.90% upside)
Analyst Consensus: Strong Buy

News

Nyxoah Announces Participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference

Nyxoah Announces Participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference

3 weeks ago - GlobeNewsWire

Nyxoah appoints new CFO

Mont-Saint-Guibert, Belgium – November 8, 2021, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development a...

4 weeks ago - GlobeNewsWire

Nyxoah Announces Participation in the Stifel 2021 Virtual Healthcare Conference

Nyxoah Announces Participation in the Stifel 2021 Virtual Healthcare Conference

1 month ago - GlobeNewsWire

Nyxoah Announces CE-Mark Indication Approval to Treat Complete Concentric Collapse (CCC) Patients

INSIDE INFORMATION REGULATED INFORMATION

2 months ago - GlobeNewsWire

Nyxoah's Sleep Apnea Device Receives FDA Breakthrough Tag

The FDA has granted Breakthrough Device Designation to Nyxoah SA (NASDAQ: NYXH) Genio bilateral hypoglossal nerve stimulation system. The system treats adult patients with moderate to severe Obstructive...

2 months ago - Benzinga

Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference

Nyxoah Announc es Participation in the Cantor 2021 Virtual Global Healthcare Conference

2 months ago - GlobeNewsWire

Publication relating to transparency notifications

PRESS RELEASE

3 months ago - GlobeNewsWire

Nyxoah Issues First Half 2021 Financial Results

REGULATED INFORMATION

3 months ago - GlobeNewsWire

Should You Buy Nyxoah (NYXH) Ahead of Earnings?

Nyxoah (NYXH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

3 months ago - Zacks Investment Research

Nyxoah Appoints Rita Johnson-Mills to its Board of Directors

Nyxoah Appoints Rita Johnson-Mills to its Board of Directors

3 months ago - GlobeNewsWire

Nyxoah to Release First Half 2021 Financial Results on August 31 and Host Earnings Conference Call on September 1, 2021

Mont-Saint-Guibert, Belgium. - August 11, 2021, 10:30 pm CET / 4:30 pm ET - Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the developmen...

3 months ago - GlobeNewsWire

Publication relating to a transparency notification

PRESS RELEASE REGULATED INFO R MATION

4 months ago - GlobeNewsWire

Nyxoah Announces Pricing of Nasdaq Public Offering

Mont-Saint-Guibert, Belgium – July 2, 2021, 2:40pm CET / 8:40am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and c...

5 months ago - GlobeNewsWire